2024
Pre-COVID-19 hospital quality and hospital response to COVID-19: examining associations between risk-adjusted mortality for patients hospitalised with COVID-19 and pre-COVID-19 hospital quality
Peter D, Li S, Wang Y, Zhang J, Grady J, McDowell K, Norton E, Lin Z, Bernheim S, Venkatesh A, Fleisher L, Schreiber M, Suter L, Triche E. Pre-COVID-19 hospital quality and hospital response to COVID-19: examining associations between risk-adjusted mortality for patients hospitalised with COVID-19 and pre-COVID-19 hospital quality. BMJ Open 2024, 14: e077394. PMID: 38553067, PMCID: PMC10982775, DOI: 10.1136/bmjopen-2023-077394.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19Hospital MortalityHospitalsHumansMedicarePandemicsRetrospective StudiesUnited StatesConceptsHospital qualityPatient experiencePre-COVID-19Medicare patientsShort-term acute care hospitalsCritical access hospitalsAcute care hospitalsFuture public health emergenciesHigher odds of mortalityIn-hospitalRisk-adjusted mortalityOdds of mortalityCare deliveryAccess hospitalsEffective careCOVID-19-related deathsAssociated with mortalityCare structuresHospital characteristicsPublic health emergencySummary scoreMedicare beneficiariesHigher oddsHospital responseRSMRs
2016
Comparing expectant management and spontaneous labor approaches in studying the effect of labor induction on cesarean delivery
Danilack VA, Triche EW, Dore DD, Muri JH, Phipps MG, Savitz DA. Comparing expectant management and spontaneous labor approaches in studying the effect of labor induction on cesarean delivery. Annals Of Epidemiology 2016, 26: 405-411.e1. PMID: 27211604, DOI: 10.1016/j.annepidem.2016.04.009.Peer-Reviewed Original ResearchConceptsCesarean deliveryLabor inductionExpectant managementRisk ratioWeek 34Week 37Comparison groupRisk of CDIntrauterine growth restrictionMother-newborn dyadsSpontaneous laborVaginal deliveryWeeks' gestationWeek 36Maternal ageSpontaneous onsetGrowth restrictionDiabetic disordersWeek 40High riskLower riskClinical practiceWeek 41Member hospitalsGestationChanges in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER
Triche E, Ruiz J, Olson K, Lo A. Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER. Clinical Neuropharmacology 2016, 39: 73-80. PMID: 26818040, DOI: 10.1097/wnf.0000000000000130.Peer-Reviewed Original ResearchConceptsDalfampridine extended releaseMultiple sclerosisWalk respondersObservational pre-post studyPre-post studyPerformance ScaleDegenerative neurological conditionDalfampridine-ERMS careFatigue scoresObservational studyResponder statusWeek 14Neurological conditionsSignificant improvementCognitive processing speedSelf-reported cognitionMood scoresWeeksSclerosisSDMTRespondersMoodDrugsDepression
2015
Genetic Risk Score for Essential Hypertension and Risk of Preeclampsia
Smith CJ, Saftlas AF, Spracklen CN, Triche EW, Bjonnes A, Keating B, Saxena R, Breheny PJ, Dewan AT, Robinson JG, Hoh J, Ryckman KK. Genetic Risk Score for Essential Hypertension and Risk of Preeclampsia. American Journal Of Hypertension 2015, 29: 17-24. PMID: 26002928, PMCID: PMC4692983, DOI: 10.1093/ajh/hpv069.Peer-Reviewed Original ResearchConceptsDiastolic blood pressureSystolic blood pressureGenetic risk scoreRisk of preeclampsiaBlood pressureEssential hypertensionRisk scoreNormotensive pregnant controlsHypertensive complicationsArterial pressurePregnant controlsWeeks' gestationPreeclamptic casesHypertensive stateEpidemiological evidenceHypertensionPreeclampsiaUS populationNonsignificant associationGenetic risk lociGenetic susceptibilitySwab samplesBuccal swab samplesGenetic riskRegression analysisGestational weight gain among American Samoan women and its impact on delivery and infant outcomes
Hawley NL, Johnson W, Hart CN, Triche EW, Ah Ching J, Muasau-Howard B, McGarvey ST. Gestational weight gain among American Samoan women and its impact on delivery and infant outcomes. BMC Pregnancy And Childbirth 2015, 15: 10. PMID: 25643752, PMCID: PMC4324802, DOI: 10.1186/s12884-015-0451-1.Peer-Reviewed Original ResearchConceptsGestational weight gainEarly pregnancy weightTrimester weight gainThird trimester weight gainAmerican Samoan womenPregnancy weightWeight gainInfant outcomesSamoan womenSecond trimester weight gainExcess gestational weight gainExcessive gestational weight gainAppropriate gestational weight gainGreater gestational weight gainMedicine GWG guidelinesPrenatal care recordsOverweight/obeseOverweight/obesityExcess weight gainLevels of obesityOutcomes of interestBinary logistic regressionAdverse pregnancyInfant overweightLGA infants
2012
Fetal growth and later maternal death, cardiovascular disease and diabetes
LYKKE JA, PAIDAS MJ, TRICHE EW, LANGHOFF‐ROOS J. Fetal growth and later maternal death, cardiovascular disease and diabetes. Acta Obstetricia Et Gynecologica Scandinavica 2012, 91: 503-510. PMID: 22372730, DOI: 10.1111/j.1600-0412.2011.01355.x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBirth WeightCardiovascular DiseasesCohort StudiesDenmarkDiabetes MellitusFemaleFetal DevelopmentFollow-Up StudiesHealth Status IndicatorsHumansInfant, NewbornMiddle AgedMortality, PrematurePregnancyProportional Hazards ModelsReference StandardsRegistriesRetrospective StudiesRiskYoung AdultConceptsSubsequent maternal deathIschemic heart diseaseFetal growthPonderal indexMaternal deathsStandardized birthweightHeart diseaseCardiovascular diseaseSubsequent mortalityCox proportional hazards modelFirst singleton deliverySmaller risk estimatesSubsequent diabetes mellitusRetrospective cohort studyProportional hazards modelCardiovascular morbidityPregnancy complicationsCohort studySingleton deliveriesDiabetes mellitusGestational ageLow birthweightPrimary exposureSubsequent riskEarly death
2010
Mortality of mothers from cardiovascular and non‐cardiovascular causes following pregnancy complications in first delivery
Lykke JA, Langhoff‐Roos J, Lockwood CJ, Triche EW, Paidas MJ. Mortality of mothers from cardiovascular and non‐cardiovascular causes following pregnancy complications in first delivery. Paediatric And Perinatal Epidemiology 2010, 24: 323-330. PMID: 20618721, DOI: 10.1111/j.1365-3016.2010.01120.x.Peer-Reviewed Original ResearchConceptsNon-cardiovascular causesGestational age offspringEarly maternal deathPreterm deliveryCardiovascular causesHypertensive disordersPregnancy complicationsMaternal deathsEarly deathRegistry-based retrospective cohort studyCox proportional hazards modelFirst singleton deliveryMortality of mothersRetrospective cohort studyProportional hazards modelDenmark 1978Placental abruptionCohort studySingleton deliveriesLarge cohortFirst deliveryMortality hazardHazards modelSubsequent deathStrong marker
2007
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy.
Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. International Journal Of Fertility And Women's Medicine 2007, 52: 59-67. PMID: 18320863.Peer-Reviewed Original ResearchMeSH KeywordsAdultAspirinCohort StudiesConfidence IntervalsDrug Therapy, CombinationFemaleFetal Growth RetardationFibrinolytic AgentsHeparin, Low-Molecular-WeightHumansInfant, NewbornLogistic ModelsOdds RatioParityPre-EclampsiaPregnancyRetrospective StudiesRisk FactorsSecondary PreventionWomen's HealthConceptsLow-dose aspirinAdverse pregnancy outcomesIntrauterine growth restrictionSevere preeclampsiaIndex pregnancyProphylactic low-dose aspirinRetrospective cohort studyIntrauterine growth retardationCohort of womenLogistic regression modelsAntithrombotic prophylaxisAntecedent pregnancyDose aspirinMultiparous patientsCohort studyMultiparous womenPregnancy outcomesWeight heparinGrowth restrictionOdds ratioPrevious historyGrowth retardationCombined treatmentLMWHPregnancyUse of recombinant activated factor VII for massive postpartum hemorrhage
HOSSAIN N, SHAMSI T, HAIDER S, SOOMRO N, KHAN NH, MEMON GU, FARZANA T, ANSARI S, TRICHE EW, KUCZYNSKI E, LOCKWOOD CJ, PAIDAS MJ. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstetricia Et Gynecologica Scandinavica 2007, 86: 1200-1206. PMID: 17851797, DOI: 10.1080/00016340701619324.Peer-Reviewed Original ResearchConceptsMassive postpartum hemorrhageDepartment of ObstetricsPostpartum hemorrhageRecombinant factor VIIFactor VIIMaternal mortalityActivated recombinant factor VIIPacked red cell transfusionSurgical intensive care unitCost of rFVIIaCorrection of coagulopathyCivil Hospital KarachiRed cell transfusionPreservation of fertilityIntensive care unitLower prothrombin timeRate of hysterectomyAdministration of drugsLower maternal mortalityCell transfusionHospital KarachiAdverse eventsBlood lossCare unitDow University